Terz
Terz is a catalog name for a synthetic, fatty-diacid-acylated peptide studied as a dual agonist of the GIP and GLP-1 receptors.
Chemistry papers describe a peptide on the order of 39 residues, with a lipid chain associated with albumin binding in animal pharmacokinetic work. Coskun et al., Molecular Metabolism, 2018 (PMID 30473097) report concurrent GIP-receptor and GLP-1-receptor engagement in vitro, with mouse pharmacology for the molecule in that study. The catalog name is a research listing. The lot sequence is whatever the certificate of analysis says.
Terz is distinct from GLP-3R, which the same literature stream also discusses at the glucagon receptor, and from Sema, discussed as a GLP-1 receptor analogue. Mixing those names across vendors, without a lot document, is a common way to mis-file a vial. The naming problem is spelled out in catalog names and paper names.
This page summarizes that receptor theme. It is not a dose and not a clinical outcome.